C4 Therapeutics, Inc. (CCCC) vs Mobia Medical, Inc. Common Stock (MOBI)
A side-by-side comparison of C4 Therapeutics, Inc. and Mobia Medical, Inc. Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CCCC
C4 Therapeutics, Inc.
$2.85HealthcareDelayed quote: Oct 6, 2026, 3:09 PM EDT
MOBI
Mobia Medical, Inc. Common Stock
$8.92HealthcareDelayed quote: Oct 6, 2026, 3:05 PM EDT
Total return — CCCC vs MOBI
growth of $100 · dividends reinvested · last 1yCCCC +0.7% (+0.7%/yr)MOBI -36.1% (-36.1%/yr)CCCC compounded faster over this window
CCCC MOBI
CCCC vs MOBI: by the numbers
- •CCCC is the larger company ($315M vs $296M market cap).
- •Both run net losses; MOBI's is the smaller (-145.12% vs -289.44% net margin).
Metrics side by side
Valuation
| Metric | CCCC | MOBI |
|---|---|---|
| P/S ratio | 8.99 | N/A |
| P/B ratio | 1.27 | 1.72 |
Profitability
| Metric | CCCC | MOBI |
|---|---|---|
| Gross margin | 77.81% | 81.07% |
| Operating margin | -290.68% | -144.71% |
| Net margin | -289.44% | -145.12% |
| ROE | -41.02% | N/A |
| ROIC | -35.92% | -122.21% |
Growth (annualized)
| Metric | CCCC | MOBI |
|---|---|---|
| Revenue CAGR (5Y) | 0.65% | N/A |
| Total return CAGR (5Y) | -41.77% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.